- Report
- January 2024
- 214 Pages
Global
€4375EUR$4,995USD£3,843GBP
- Report
- January 2024
- 170 Pages
Global
€4375EUR$4,995USD£3,843GBP
- Report
- December 2023
- 182 Pages
Global
€4375EUR$4,995USD£3,843GBP
- Report
- November 2023
- 381 Pages
Global
€4375EUR$4,995USD£3,843GBP
- Report
- October 2023
- 240 Pages
Global
€4200EUR$4,795USD£3,689GBP
- Report
- August 2023
- 220 Pages
Global
€4024EUR$4,595USD£3,535GBP
- Report
- December 2025
- 150 Pages
Germany
From €3372EUR$3,850USD£2,962GBP
€4248EUR$4,850USD£3,731GBP
- Report
- November 2025
- 150 Pages
India
From €3372EUR$3,850USD£2,962GBP
€4248EUR$4,850USD£3,731GBP
- Report
- November 2025
- 150 Pages
Japan
From €3372EUR$3,850USD£2,962GBP
€4248EUR$4,850USD£3,731GBP
- Report
- November 2025
- 150 Pages
China
From €3372EUR$3,850USD£2,962GBP
€4248EUR$4,850USD£3,731GBP
- Report
- November 2024
- 150 Pages
Global
From €3372EUR$3,850USD£2,962GBP
€4248EUR$4,850USD£3,731GBP
- Report
- September 2024
- 150 Pages
Global
From €3372EUR$3,850USD£2,962GBP
€4248EUR$4,850USD£3,731GBP
- Report
- March 2024
- 150 Pages
Global
From €3372EUR$3,850USD£2,962GBP
€4248EUR$4,850USD£3,731GBP
- Report
- January 2024
- 150 Pages
Global
From €3372EUR$3,850USD£2,962GBP
€4248EUR$4,850USD£3,731GBP
- Report
- January 2024
- 150 Pages
Global
From €3372EUR$3,850USD£2,962GBP
€4248EUR$4,850USD£3,731GBP
- Report
- January 2024
- 150 Pages
Global
From €3372EUR$3,850USD£2,962GBP
€4248EUR$4,850USD£3,731GBP
- Report
- January 2024
- 150 Pages
Global
From €3372EUR$3,850USD£2,962GBP
€4248EUR$4,850USD£3,731GBP
- Report
- November 2023
- 150 Pages
Global
From €3372EUR$3,850USD£2,962GBP
€4248EUR$4,850USD£3,731GBP
- Report
- January 2025
- 103 Pages
Global
From €3500EUR$4,281USD£3,182GBP
- Report
- January 2025
- 237 Pages
Global
From €4375EUR$4,995USD£3,843GBP

The Central Nervous System Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs that target the central nervous system. These drugs are used to treat a variety of conditions, including neurological disorders, mental health issues, and pain management. The market is composed of a variety of companies, ranging from large multinationals to small start-ups.
The Central Nervous System Drugs market is highly competitive, with companies competing to develop the most effective and safe treatments. Companies in the market are constantly researching and developing new drugs, as well as improving existing treatments. Many of these companies are also involved in clinical trials to test the safety and efficacy of their products.
Some of the major companies in the Central Nervous System Drugs market include Pfizer, GlaxoSmithKline, Merck, Novartis, and Johnson & Johnson. These companies are involved in the development and production of a wide range of CNS drugs, including antidepressants, antipsychotics, and anticonvulsants. Show Less Read more